| Literature DB >> 28793551 |
Anna Janaszewska1, Kinga Gradzinska2, Monika Marcinkowska3, Barbara Klajnert-Maculewicz4,5, Wlodzimierz A Stanczyk6.
Abstract
As scientific literature considers polyhedral oligosilsesquioxanes (POSS) as potential drug delivery systems, it is necessary to check their impact on mammalian cells. Toxicity of octaammonium chloride salt of octaaminopropyl polyhedral oligomeric silsesquioxane (oap-POSS) towards two cell lines: mouse neuroblastoma (N2a) and embryonic mouse hippocampal cells (mHippoE-18) was studied. Experiments consisted of analysis of a cell cycle, cell viability, amount of apoptotic and necrotic cells, and generation of reactive oxygen species (ROS). POSS caused a shift in the cell population from the S and M/G₂ phases to the G₀/G₁ phase. However, the changes affected less than 10% of the cell population and were not accompanied by increased cytotoxicity. POSS did not induce either apoptosis or necrosis and did not generate reactive oxygen species. A cytotoxicity profile of POSS makes it a promising starting material as drug carrier.Entities:
Keywords: MTT assay; POSS; apoptosis; cell cycle; in vitro toxicity; necrosis; reactive oxygen species; silsesquioxane
Year: 2015 PMID: 28793551 PMCID: PMC5512898 DOI: 10.3390/ma8095291
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1The structure of octaammonium chloride salt of octaaminopropyl polyhedral oligomeric silsesquioxane (oap-POSS), R = -(CH2)3NH3Cl.
Figure 2Cell population histograms for N2a cells (a,b) and mHippoE-18 cells (c,d) that were untreated (control) and upon incubation with 1 mM POSS for 24 h (a,c) and 48 h (b,d).
Cell cycle analysis for control untreated cells and cells treated with 1 mM POSS. Each result represents a mean and SD taken from n ≥ 6 wells from 3 independent experiments. (*) p < 0.05; (**) p < 0.001.
| N2a | G0/G1 | S | M/G2 | |
|---|---|---|---|---|
| 24 h | Control | 52.70 ± 0.52 | 13.23 ± 0.93 | 29.77 ± 0.80 |
| 1 mM POSS | 54.57 * ± 0.49 | 11.40 * ± 0.50 | 29.53 ± 0.61 | |
| 48 h | Control | 53.67 ± 0.65 | 13.57 ± 0.70 | 30.40 ± 1.36 |
| 1 mM POSS | 62.63 ** ± 0.91 | 11.57 ± 0.90 | 22.83 ** ± 0.17 | |
| 24 h | Control | 54.17 ± 0.97 | 12.57 ± 0.68 | 29.13 ± 0.40 |
| 1 mM POSS | 52.83 ± 0.49 | 11.83 ± 0.95 | 30.77 ± 0.40 | |
| 48 h | Control | 48.50 ± 0.87 | 13.33 ± 0.15 | 28.93 ± 1.10 |
| 1 mM POSS | 57.17 ** ± 0.29 | 9.67 ** ± 0.55 | 26.23 ** ± 0.60 | |
Figure 3Flow cytometry analysis of the ability of POSS to induce necrosis or apoptosis assayed by Annexin V-FITC and PI fluorescence (V—viable cells; A—apoptotic cells; N—necrotic cells; FITC-A—fluorescence of Annexin V; PE-A—fluorescence of PI). Fractions of apoptotic and necrotic cells after 24 h and 48 h incubation with POSS in a concentration of 1 mM are presented for N2a cells (a,c,e) and mHippoE-18 cells (b,d,f).